Hourglass Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.76M | Sell |
347,598
-90,550
| -21% | -$2.41M | 2.03% | 14 |
|
|
2025
Q4 | $10.9M | Sell |
438,148
-32,390
| -7% | -$817K | 2.35% | 8 |
|
|
2025
Q3 | $12M | Buy |
470,538
+34,098
| +8% | +$842K | 2.69% | 4 |
|
|
2025
Q2 | $10.6M | Buy |
436,440
+35,900
| +9% | +$837K | 2.62% | 6 |
|
|
2025
Q1 | $10.1M | Buy |
400,540
+2,820
| +0.7% | +$73.8K | 2.66% | 4 |
|
|
2024
Q4 | $10.6M | Buy |
397,720
+117,820
| +42% | +$3.2M | 2.91% | 1 |
|
|
2024
Q3 | $8.1M | Sell |
279,900
-7,410
| -3% | -$216K | 2.26% | 9 |
|
|
2024
Q2 | $8.04M | Buy |
287,310
+5,750
| +2% | +$158K | 2.39% | 7 |
|
|
2024
Q1 | $7.81M | Buy |
281,560
+5,950
| +2% | +$165K | 2.35% | 7 |
|
|
2023
Q4 | $7.93M | Buy |
275,610
+170,631
| +163% | +$5.16M | 2.56% | 5 |
|
|
2023
Q3 | $3.48M | Buy |
104,979
+5,340
| +5% | +$189K | 1.23% | 37 |
|
|
2023
Q2 | $3.65M | Buy |
99,639
+36,198
| +57% | +$1.41M | 1.27% | 36 |
|
|
2023
Q1 | $2.59M | Sell |
63,441
-31
| -0% | -$1.34K | 0.93% | 45 |
|
|
2022
Q4 | $3.25M | Buy |
63,472
+70
| +0.1% | +$3.36K | 1.15% | 38 |
|
|
2022
Q3 | $2.77M | Buy |
63,402
+400
| +0.6% | +$19.4K | 1.05% | 45 |
|
|
2022
Q2 | $3.3M | Sell |
63,002
-20
| -0% | -$1.02K | 1.17% | 38 |
|
|
2022
Q1 | $3.26M | Sell |
63,022
-52,970
| -46% | -$2.75M | 1.02% | 43 |
|
|
2021
Q4 | $6.85M | Sell |
115,992
-27,196
| -19% | -$1.35M | 2.29% | 14 |
|
|
2021
Q3 | $6.16M | Sell |
143,188
-19,772
| -12% | -$876K | 1.68% | 21 |
|
|
2021
Q2 | $6.38M | Buy |
162,960
+3,589
| +2% | +$140K | 1.49% | 27 |
|
|
2021
Q1 | $5.77M | Sell |
159,371
-2,286
| -1% | -$81.2K | 1.46% | 28 |
|
|
2020
Q4 | $5.95M | Sell |
161,657
-27,965
| -15% | -$1.03M | 1.77% | 20 |
|
|
2020
Q3 | $6.6M | Buy |
189,622
+3,858
| +2% | +$135K | 2.23% | 12 |
|
|
2020
Q2 | $5.76M | Buy |
185,764
+39
| +0% | +$1.32K | 2.04% | 15 |
|
|
2020
Q1 | $5.75M | Sell |
185,725
-3,639
| -2% | -$124K | 2.44% | 8 |
|
|
2019
Q4 | $7.04M | Buy |
189,364
+23,178
| +14% | +$826K | 1.91% | 16 |
|
|
2019
Q3 | $5.67M | Sell |
166,186
-10,856
| -6% | -$395K | 1.61% | 31 |
|
|
2019
Q2 | $7.28M | Buy |
177,042
+6,587
| +4% | +$262K | 2.06% | 17 |
|
|
2019
Q1 | $6.87M | Sell |
170,455
-1,148
| -0.7% | -$46K | 2% | 21 |
|
|
2018
Q4 | $7.11M | Buy |
171,603
+2,258
| +1% | +$93.7K | 2.24% | 14 |
|
|
2018
Q3 | $7.08M | Sell |
169,345
-6,999
| -4% | -$269K | 1.84% | 21 |
|
|
2018
Q2 | $6.07M | Sell |
176,344
-12,648
| -7% | -$432K | 1.52% | 30 |
|
|
2018
Q1 | $6.36M | Buy |
188,992
+13,123
| +7% | +$451K | 1.45% | 30 |
|
|
2017
Q4 | $6.04M | Sell |
175,869
-643
| -0.4% | -$21.9K | 1.37% | 32 |
|
|
2017
Q3 | $5.98M | Buy |
176,512
+442
| +0.3% | +$14.2K | 1.42% | 34 |
|
|
2017
Q2 | $5.61M | Buy |
176,070
+1,739
| +1% | +$54.8K | 1.41% | 34 |
|
|
2017
Q1 | $5.66M | Buy |
174,331
+886
| +0.5% | +$27.9K | 1.37% | 33 |
|
|
2016
Q4 | $5.34M | Sell |
173,445
-2,193
| -1% | -$66.9K | 1.32% | 35 |
|
|
2016
Q3 | $5.64M | Sell |
175,638
-8,368
| -5% | -$280K | 1.4% | 32 |
|
|
2016
Q2 | $6.15M | Buy |
184,006
+3,056
| +2% | +$97.5K | 1.52% | 28 |
|
|
2016
Q1 | $5.09M | Buy |
180,950
+5,376
| +3% | +$154K | 1.3% | 33 |
|
|
2015
Q4 | $5.38M | Sell |
175,574
-86,291
| -33% | -$2.71M | 1.39% | 36 |
|
|
2015
Q3 | $7.8M | Sell |
261,865
-1,044
| -0.4% | -$33.5K | 1.7% | 19 |
|
|
2015
Q2 | $8.36M | Sell |
262,909
-1,813
| -0.7% | -$59.1K | 1.31% | 18 |
|
|
2015
Q1 | $8.74M | Buy |
264,722
+2,214
| +0.8% | +$70.4K | 1.31% | 18 |
|
|
2014
Q4 | $7.76M | Sell |
262,508
-211
| -0.1% | -$6.05K | 1.4% | 19 |
|
|
2014
Q3 | $7.37M | Buy |
262,719
+103,187
| +65% | +$2.9M | 0.98% | 29 |
|
|
2014
Q2 | $4.49M | Buy |
159,532
+1,633
| +1% | +$46.5K | 0.65% | 55 |
|
|
2014
Q1 | $4.81M | Sell |
157,899
-6,534
| -4% | -$195K | 0.8% | 51 |
|
|
2013
Q4 | $4.78M | Sell |
164,433
-9,708
| -6% | -$283K | 0.76% | 50 |
|
|
2013
Q3 | $4.75M | Buy |
174,141
+3,552
| +2% | +$96.6K | 0.83% | 47 |
|
|
2013
Q2 | $4.53M | Buy |
+170,589
| New | +$4.71M | 0.83% | 48 |
|
Other funds holding PFE
VCM
VPM
Hourglass Capital's PFE Position: Q1 2026 in Review
Hourglass Capital reduced its Pfizer (PFE) stake by 21% in Q1 2026, selling an estimated $2.41M and leaving 347,598 shares worth $9.76M. The position accounts for 2.03% of the portfolio, ranked #14.
Hourglass Capital first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q3 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Hourglass Capital held 347,598 shares of Pfizer worth $9.76M as of Q1 2026.
- Hourglass Capital sold 90,550 Pfizer shares in Q1 2026, an estimated $2.41M.
- Pfizer made up 2.03% of Hourglass Capital's portfolio in Q1 2026, its #14 holding.
- Hourglass Capital first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Hourglass Capital's Pfizer position peaked at $12M in Q3 2025.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Hourglass Capital's 13F filing for Q1 2026, filed 4 May 2026.